非增强MRI方案用于特定儿童垂体内分泌疾病:诊断率高且可减少麻醉和钆对比剂暴露
本研究回顾2010-2019年因生长激素缺乏、中枢性性早熟或矮小症行垂体MRI的0-18岁患者,对原始报告异常者由2名儿科神经放射学家盲法复核非增强图像,与原始报告一致率70%,仅9/40例不一致需增强进一步表征,提示多数相关表现无需对比剂即可检出。
要点
- 生长激素缺乏、中枢性性早熟或矮小症患儿,非增强垂体MRI可检出多数相关异常。
- 盲法复核非增强图像与原始报告一致率70%,仅少数不一致需增强。
- 提出「快速非增强垂体」方案,可减少对比剂和麻醉暴露。
局限性
- 回顾性研究设计。
- 仅对原始报告异常者进行盲法复核,未评估正常报告者的非增强诊断效能。
- 单中心研究,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Although many pediatric neuroradiology practices empirically use noncontrast brain and pituitary MR imaging for evaluation of growth hormone deficiency, central precocious puberty, and short stature, there are currently insufficient published data to support this practice in an evidence-based fashion. Therefore, the use of contrast-enhanced MR imaging for all pediatric pituitary endocrinopathies remains widespread. We evaluated whether noncontrast MR imaging has adequate diagnostic yield for the evaluation of pediatric growth hormone deficiency, central precocious puberty, and short stature.
MATERIALS AND METHODS: Pituitary MR imaging studies obtained for growth hormone deficiency, central precocious puberty, or short stature in patients 0-18 years of age from 2010 to 2019 were analyzed. Separate blinded review of noncontrast images in cases with abnormalities on the original radiology report was performed by 2 subspecialty-trained pediatric neuroradiologists, with discrepancies resolved by consensus.
RESULTS: Of the 134/442 MR imaging studies obtained for growth hormone deficiency, central precocious puberty, or short stature with hypothalamic-pituitary region abnormalities, there was 70% concordance with the original reports on blinded review of noncontrast images. Twenty-two of 40 discrepancies were deemed unrelated to the indication, and 9 cases originally interpreted as possible microadenoma were read as having normal findings on blinded review. Only 9 of 40 discrepancies required contrast for further characterization.
CONCLUSIONS: In our study, most relevant radiologic findings in patients with growth hormone deficiency, central precocious puberty, and short stature were detectable without contrast, providing evidence that contrast can be avoided in routine MR imaging evaluation of these indications. We propose a "rapid noncontrast pituitary" MR imaging protocol for pediatric patients presenting with growth hormone deficiency, central precocious puberty, or short stature, which may increase efficiency and decrease contrast and anesthesia exposure.
引用
- Huang J, Sarma A, Gupta N, et al. Noncontrast MRI Protocol for Selected Pediatric Pituitary Endocrinopathies: A Procedure with High Diagnostic Yield and Potential to Reduce Anesthesia and Gadolinium-Based Contrast Exposure. AJNR Am J Neuroradiol. 2021. PMID: 34475192. doi:10.3174/ajnr.A7228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。